Aim: Acute limb ischemia occurs after the embolism or thrombosis and if it is not treated it may result in limb loss and even death. In addition, late diagnosis eliminates the chance of immediate intervention. Therefore, early diagnosis is crucial. It has been reported that ischemic modified albumin levels are known to be increased in acute ischemic conditions such as myocardial, cerebral and pulmonary infarctions. The aims of this study were to determine the levels of ischemic modified albumin in lower limb ischemia and to investigate its usability as an auxiliary parameter for early diagnosis. Materials and Methods: 24 patients (5 females, 19 males) with lower limb ischemia (patient group: 23-89 years old), 34 healthy individuals composed of 19 females and 15 males (control group; 20-75 years old) who were totally 58 cases were included in the study. The ischemic modified albumin levels in the serum samples obtained from individuals in the patient and control groups who met the inclusion criteria, were analyzed with the ELISA kit (Organo Teknika, Austria) in line with the manufacturer's instructions. Mann Whitney U test was used to compare ischemic modified albumin levels between groups. Results: It was found that patients with limb ischemia had a significantly increased ischemic modified albumin level compared to the control group (p <0.001). It was detected that the sensitivity value was 91.7 and the specificity value was 82.4 in the ROC curve analysis. Conclusion: We think that the significant increase in serum ischemic modified albumin levels in lower limb ischemia may be useful in the diagnosis of limb ischemia.
Amaç: Akut ekstremite iskemisi, emboli ya da tromboz akabinde ortaya çıkmakta ve tedavi edilmezse ekstremite kaybı ve hatta ölümle sonuçlanabilmektedir. Ayrıca, tanının gecikmesi acil girişim şansını ortadan kaldırmaktadır. Bu nedenle, erken tanı büyük önem taşımaktadır. Miyokard enfarktüsü, serebral infarkt ve pulmoner infarkt gibi akut iskemik durumlarda düzeylerinin yükseldiği bildirilen iskemi modifiye albüminin, iskemik durumlarda tanı belirteci olabileceği bildirilmektedir. Bu çalışmanın amacı da alt ekstremite iskemisinde iskemi modifiye albüm düzeyini belirlemek ve erken tanıya yardımcı bir parametre olarak kullanılabilirliğini araştırmaktır. Yöntem: Bu çalışmaya alt ekstremite iskemisi olan 5’i kadın, 19’u erkekten oluşan 24 hasta (hasta grubu; 23-89 yaş) ve kontrol amaçlı gelen 19’u kadın, 15’i erkekten oluşan 34 sağlıklı gönüllü (kontrol gurubu; 20-75 yaş) olmak üzere 58 kişi dahil edildi. Dahil edilme kriterlerine uygun hasta ve kontrol gruplarındaki bireylerden elde edilen serum örneklerindeki iskemi modifiye albüm düzeyleri, ELİSA kiti (Organo Teknika, Avusturya) ile analiz edildi. Gruplar arası iskemi modifiye albüm düzeylerinin karşılaştırılmasında Mann Whitney U testi kullanıldı. Bulgular: Akut ekstremite iskemisi olan hastalarda, kontrol grubundakiler ile karşılaştırıldığında önemli ölçüde artmış iskemi modifiye albüm düzeyi olduğu tespit edildi (p <0.001). ROC eğrisi analizinde sensitivite değeri 91.7 ve spesifite değeri 82.4 olarak tespit edildi. Sonuç: Alt ekstremite iskemisinde serum iskemi modifiye albüm düzeylerinde görülen önemli artışın, ekstremite iskemisinin tanısında yararlı olabileceğini düşünmekteyiz.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Publication Date | August 25, 2021 |
Submission Date | December 8, 2020 |
Acceptance Date | February 8, 2021 |
Published in Issue | Year 2021 Volume: 14 Issue: 2 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.